Back to Search
Start Over
Author Correction: Tau-targeting antisense oligonucleotide MAPTRxin mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial
- Source :
- Nature Medicine; January 2024, Vol. 30 Issue: 1 p304-304, 1p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 10788956 and 1546170X
- Volume :
- 30
- Issue :
- 1
- Database :
- Supplemental Index
- Journal :
- Nature Medicine
- Publication Type :
- Periodical
- Accession number :
- ejs64256043
- Full Text :
- https://doi.org/10.1038/s41591-023-02639-3